ALPMY
ASTELLAS PHARMA/ADR

308
Loading...
Loading...
Upcoming Earnings: Q2 '25
Reports: Oct 30,
After Hours

Estimated EPS

$0.19

Estimated Rev

$3.23B

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q2 '25
$0.19
--
--
N/A
Q1 '25
$0.14
$0.25
87.25%
BEAT
Q4 '24
$0.15
$0.29
98.67%
BEAT
Q3 '24
$0.16
-$0.36
-326.91%
MISSED
Q2 '24
$0.12
$0.13
8.98%
BEAT

Latest ALPMY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.